GlassScriptPhysician profile
Maxim Shaydakov
NPI 1780118679
$9,081.05
in general payments reported to CMS, 2019-2025
14 companies · $2,257 in 2025
The $2,257 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $221 · 2023: $2,770 · 2024: $3,834 · 2025: $2,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,342 · Food and Beverage: $2,436 · Education: $1,674 · Travel and Lodging: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,342.14 |
| Food and Beverage | $2,436.08 |
| Education | $1,673.63 |
| Travel and Lodging | $1,408.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,919.22 | 2023-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $1,854.71 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis, Gore-Tex Vascular Graft |
| Penumbra, INC. | $1,740.43 | 2025 | Indigo System |
| Cook Incorporated | $1,384.76 | 2023 | |
| Bard Peripheral Vascular, INC. | $270.60 | 2023 | Venclose Maven Catheter |
| Inari Medical, INC. | $152.65 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $132.99 | 2024 | Ranger |
| Integra Lifesciences Corporation | $131.94 | 2022 | |
| Stryker Corporation | $107.67 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Davol INC. | $105.42 | 2024 | Arista Ah Flexitip |
| Lexicon Pharmaceuticals, INC. | $94.09 | 2024 | |
| Intuitive Surgical, INC. | $88.75 | 2022 | |
| Philips North America LLC | $71.74 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.08 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxim Shaydakov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.